Press Releases

Jun 1, 2026

Priya Menon

Press Releases

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

LIXTE Biotechnology Holdings, Inc. announced a strategic transformation from a clinical-stage pharmaceutical company into an AI energy infrastructure equipment and services platform. The company will focus on addressing the growing power demands of AI and hyperscale data centers in North America. Stuart D. Porter, founder of Denham Capital, with ex…

LIXT

Jun 1, 2026

Ajmal Hussain

Press Releases

Syntec Optics (Nasdaq: OPTX) Announces Inclusion in Russell 3000 Index

Syntec Optics (Nasdaq: OPTX), a U.S.-based leader in optics and photonics manufacturing for defense, space, and biomedical technologies, announced its inclusion in the Russell 3000 Index effective June 26, 2026. This milestone reflects the company's meeting of key market capitalization and liquidity thresholds and is expected to increase institutio…

OPTX

Jun 1, 2026

Leila Farooq

Press Releases

Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Outlook Therapeutics announced it has resubmitted its Biologics License Application (BLA) to the U.S. FDA for ONS-5010/LYTENAVA™, a treatment for neovascular age-related macular degeneration (nAMD). Following a successful appeal of a previous Complete Response Letter, the FDA confirmed substantial evidence of effectiveness for the drug and classifi…

OTLK

Jun 1, 2026

Priya Menon

Press Releases

Verisk Redefines U.S. Hurricane Risk Modeling with Reengineered Tropical Cyclone Model, Delivered on Its New Synergy Studio Platform

Verisk Analytics introduced a reengineered U.S. Tropical Cyclone (hurricane) model delivered via its cloud-native Synergy Studio platform. The update incorporates advanced climate science, enhanced hazard and vulnerability modeling, and improved representation of storm surge, wind, and inland flooding risks. Designed to provide insurers, reinsurers…

VRSK

Jun 1, 2026

Hana Yamamoto

Press Releases

Fusemachines Appoints Renowned AI Pioneer Dr. Julia Hirschberg to Board of Directors

Fusemachines Inc., a NASDAQ-listed provider of enterprise AI products and services, has appointed Dr. Julia Hirschberg, a distinguished AI researcher and educator, to its Board of Directors. Dr. Hirschberg brings extensive expertise in natural language processing, speech technology, and AI governance, enhancing Fusemachines' commitment to responsib…

FUSE

Jun 1, 2026

Derek Hwang

Press Releases

Maris-Tech Unveils Venus-Space, Expanding AI-Powered Edge Video Solutions to Low Earth Orbit Nano Satellites

Maris-Tech Ltd. has announced the development of Venus-Space, an advanced AI-powered edge video processing platform tailored for low Earth orbit nano satellites. Leveraging upgraded capabilities from its Venus-Pro system, Venus-Space enables ultra-high-resolution video acquisition, onboard AI inference, and real-time streaming, significantly reduci…

MTEK

Jun 1, 2026

Jordan Park

Press Releases

ParaZero Secures First DefendAir Order from U.S.-Based Tier-1 Defense Corporation

ParaZero Technologies Ltd., an aerospace defense company specializing in smart autonomous air systems, announced its first order from a major U.S.-based Tier-1 defense corporation for its DefendAir Net Pods. This order supports integration of ParaZero's non-explosive, net-based Counter-UAS interception technology into advanced autonomous defense ap…

PRZO

Jun 1, 2026

Leila Farooq

Press Releases

Uniti Group Inc. Announces Launch of Second Kinetic Fiber Securitization Notes Offering

Uniti Group Inc. announced the commencement of a $1.14 billion offering of secured fiber network revenue term notes backed by residential fiber assets across multiple U.S. states. The notes are expected to mature in June 2033, with proceeds intended for general corporate purposes such as capital expenditures and debt repayment. The offering is targ…

UNIT

Jun 1, 2026

Derek Hwang

Press Releases

Rezolve Ai Positioned at the Heart of the AI Transformation of $30 Trillion Global Retail, Reiterates $360M+ FY26 Revenue Guidance

Rezolve Ai PLC, trading on NASDAQ as RZLV, reaffirmed its FY26 revenue guidance of approximately $360 million, demonstrating strong confidence backed by accelerating enterprise adoption and conversion of its commercial pipeline. The company reported Q1 2026 revenue of $60 million, surpassing its total 2025 revenue, highlighting significant growth d…

RZLV

Jun 1, 2026

Leila Farooq

Press Releases

Wave Life Sciences to Present at Upcoming Investor Conferences

Wave Life Sciences Ltd., a clinical-stage biotechnology company specializing in RNA medicines, announced that its CEO will participate in two major healthcare investor conferences in June 2026. These events provide an opportunity to showcase the company's innovative RNA platform and diverse clinical pipeline targeting various genetic diseases.

WVE

Jun 1, 2026

Leila Farooq

Press Releases

Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients

Disc Medicine has initiated an expanded access program for its oral GlyT1 inhibitor, bitopertin, allowing eligible U.S. patients with erythropoietic protoporphyria (EPP) early access prior to regulatory approval. Bitopertin is currently in a Phase 3 trial with topline data expected in Q4 2026 and a potential FDA decision anticipated by mid-2027, ai…

IRON

Jun 1, 2026

Caleb Monroe

Press Releases

Plexus Issues Fiscal 2025 Sustainability Report and Announces Transition to Absolute Emission Reduction Targets

Plexus Corp. has released its Fiscal 2025 Sustainability Report, marking a strategic move from intensity-based to absolute emission reduction targets. The company commits to reducing emissions by 2033, has doubled its zero waste sites, enhanced social impact contributions, and improved team member well-being programs, underscoring its dedication to…

PLXS

Jun 1, 2026

Derek Hwang

Press Releases

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

IN8bio announced updated clinical data showing that repeat dosing of DeltEx DRI, a gamma-delta T cell therapy, combined with standard-of-care treatment significantly improved median progression-free and overall survival in newly diagnosed glioblastoma patients. Median overall survival exceeded 19.5 months, roughly 48% longer than with standard care…

IN8B

Jun 1, 2026

Priya Menon

Press Releases

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

PolyPid Ltd. has completed the New Drug Application submission to the FDA for D-PLEX100, its lead product candidate aimed at preventing surgical site infections in colorectal surgery patients. The submission follows positive Phase 3 trial results showing a 60% reduction in infection risk and the drug currently holds multiple FDA designations includ…

PYPD

Jun 1, 2026

Sofia Navarro

Press Releases

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

Jet.AI Inc., a NASDAQ-listed company that provides high-performance GPU infrastructure and AI cloud services, announced that leading proxy advisory firm Glass Lewis recommends stockholders vote in favor of the company's proposed merger with flyExclusive. The Jet.AI Board supports this recommendation and urges stockholders to vote promptly to comple…

JTAI

Jun 1, 2026

Avery Klein

Press Releases

Fast Track Entertainment Brings Dream Cruises’ 10th Anniversary Celebrity Strategy to Life with Chef Tommie Lee Onboard ‘Genting Dream’

Fast Track Group, a Nasdaq-listed entertainment and event management company, announced a multi-part celebrity partnership with Dream Cruises to celebrate its 10th anniversary. The campaign includes exclusive appearances by Chef Tommie Lee onboard the Genting Dream cruise, and upcoming wellness and entertainment components featuring South Korean fi…

FTRK

Jun 1, 2026

Priya Menon

Press Releases

T3 Defense to Participate in the Noble Capital Markets Virtual Equity Conference on June 3-4

T3 Defense Inc., a NASDAQ-listed defense company specializing in acquiring and operating mission-critical defense businesses, announced its participation in the Noble Capital Markets Virtual Equity Conference on June 3-4, 2026. CEO Menny Shalom will engage with investors during the event, with a main presentation scheduled for June 4. The company f…

DFNS

Jun 1, 2026

Hana Yamamoto

Press Releases

Rocky Mountain Chocolate Factory Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Rocky Mountain Chocolate Factory announced its fiscal fourth quarter and full year 2026 financial results, highlighting significant operational changes that led to improved product margins but lower overall revenue. The company continues to focus on operational efficiencies, enhancing data analytics, and franchise development despite reporting a ne…

RMCF

Jun 1, 2026

Sofia Navarro

Press Releases

reAlpha (NASDAQ: AIRE) to Host “AIRE Time With Mike” Fireside Chat Moderated by Benchmark Analyst Daniel Kurnos

reAlpha Tech Corp., an AI-driven real estate technology company listed on NASDAQ under ticker AIRE, will host a live X Spaces fireside chat featuring its CEO and CFO alongside a Benchmark analyst. The discussion will focus on housing market conditions, mortgage industry trends, AI applications in real estate, and reAlpha's strategic positioning.

AIRE

Jun 1, 2026

Priya Menon

Press Releases

National Healthcare Properties Provides Business Updates

National Healthcare Properties, Inc. reported significant growth in its SHOP acquisitions pipeline valued at approximately $279 million, expected to add over 1,200 units to its senior housing portfolio. Additionally, the company's Class A common stock will be included in the Russell 2000 and 3000 Indexes, reflecting its expanding market presence af…

NHP

Jun 1, 2026

Sofia Navarro

Press Releases

INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting

INNOVATE Corp. announced the successful closing of a $105 million refinancing transaction for its broadcasting subsidiary HC2 Broadcasting Holdings Inc. Concurrently, INNOVATE entered into a definitive agreement to sell a 75% controlling interest in Broadcasting to CONX CORP, retaining 25% ownership. The transaction, subject to customary regulatory…

VATE

Jun 1, 2026

Nina Shah

Press Releases

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Fate Therapeutics showcased early Phase 1 clinical data for its off-the-shelf CAR T-cell therapy FT836 at the ASCO Annual Meeting, highlighting meaningful tumor reductions in KRAS wild-type metastatic colorectal cancer patients without the need for conditioning chemotherapy. The therapy utilizes novel Sword and Shield technology, enabling persisten…

FATE

Jun 1, 2026

Derek Hwang

Press Releases

U.S. Army Testing Shows Iperionx Titanium Fasteners Exceed Grade 8 Steel Torque-To-Yield Performance

IperionX Limited announced that titanium fasteners produced with its patented technologies performed substantially better than high-strength SAE Grade 8 steel fasteners in independent tests conducted by the U.S. Army DEVCOM Ground Vehicle Systems Center and Westmoreland Mechanical Testing & Research. The titanium fasteners demonstrated superior tor…

IPX

Jun 1, 2026

Sofia Navarro

Press Releases

NYSE: MMA Investor and Strategic Advisor Conor McGregor’s UFC Return Sparks Ticket Frenzy Ahead of July 11 in Las Vegas

Mixed Martial Arts Group Limited (NYSE American: MMA), operating as MMA.INC, announced that Conor McGregor's return to UFC competition on July 11, 2026 has triggered unprecedented ticket demand and global fan engagement. As McGregor serves as both investor and strategic advisor, the company aims to capitalize on the heightened attention through its…

MMA

Jun 1, 2026

Avery Klein

Press Releases

Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026

Celcuity Inc., a clinical-stage biotech company, announced a conference call on June 2, 2026, to discuss results from the PIK3CA mutant cohort of its Phase 3 VIKTORIA-1 clinical trial. This trial evaluates Gedatolisib, a novel PI3K/mTOR inhibitor, in combination regimens for treating hormone receptor positive, HER2-negative advanced breast cancer. …

CELC